The three Big Pharma companies on their earnings calls this week tried to reassure investors that they have the global footprints to mitigate the effects of tariffs.
Ferring Pharmaceuticals has expanded Adstiladrin production with a new facility in Parsippany, New Jersey, adding to existing sites in Kuopio, Finland.
